Dr. Mayo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1801 Inwood Rd
Dallas, TX 75235Phone+1 214-645-0595Fax+1 214-645-0581- Is this information wrong?
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 1993 - 1996
- University of California (Irvine)Residency, Internal Medicine, 1990 - 1993
- Baylor College of MedicineClass of 1990
Certifications & Licensure
- CA State Medical License 1992 - Present
- TX State Medical License 1992 - 2024
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (AGAF) American Gastroenterological Association, 2011
Clinical Trials
- Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- Systemic Complications of Primary Biliary Cholangitis.Mariana Zapata, Hendrick Pagan-Torres, Marlyn J Mayo> ;Clinics in Liver Disease. 2024 Feb 1
- Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.Marlyn J Mayo, John M Vierling, Christopher L Bowlus, Cynthia Levy, Gideon M Hirschfield, Guy W Neff, Michael R Galambos, Stuart C Gordon, Brian B Borg, Stephen A Harr...> ;Alimentary Pharmacology & Therapeutics. 2023 Oct 30
- Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.Marlyn J Mayo, Elizabeth Carey, Helen T Smith, Andrea R Mospan, Megan McLaughlin, April Thompson, Heather L Morris, Robert Sandefur, W Ray Kim, Christopher Bowlus, , C...> ;Digestive Diseases and Sciences. 2023 Oct 1
- Join now to see all
Journal Articles
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver DiseasesMarlyn (Krampitz) Mayo, MD, Hepatology
Authored Content
- The Liver Meeting's Highlights and LowlightsNovember 2023
Press Mentions
- Study Outlines Risk Factors for Autoimmune Hepatitis After Liver TransplantMay 20th, 2022
- CymaBay Therapeutics to Host Post-AASLD Key Opinion Leader Webinar on Seladelpar for Primary Biliary CholangitisNovember 11th, 2021
- CymaBay Therapeutics Inc. (CBAY) Q3 2021 Earnings Call TranscriptNovember 10th, 2021
- Join now to see all
Grant Support
- Ursodeoxycholic Acid (UDCA) In Primary Biliary CirrhosisNational Center For Research Resources2007
- UDCA Amp;Methotrexate For Primary Biliary CirrhosisNational Center For Research Resources2007
- Treatment Of Metabolic PruritisNational Center For Research Resources2004–2007
- UDCA &Methotrexate For Primary Biliary CirrhosisNational Center For Research Resources2006
- Longitudinal Studies Of Primary Biliary CirrhosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- 1treatment Of Cholestatic Pruritus With SertralineNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Role Of CD40-CD40 Ligand In Primary Biliary CirrhosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2003
- Role Of CD40 Ligand In Primary Biliary CirrhosisNational Center For Research Resources1998–2002
Committees
- Member, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD) 2016 - Present
Professional Memberships
- Fellow
Hospital Affiliations
- University of Texas Southwestern Medical CenterDallas, Texas
- Parkland Health & Hospital SystemDallas, Texas
- William P. Clements, Jr. University HospitalDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: